Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex

J. Zawistowski; M. Miller; D. Goulet; T. Stuhlmiller; A. Beltran; J. Olivares-Quintero; D. Singh; N. Sciaky; J. Parker; N. Rashid; X. Chen; J. Duncan; M. Whittle; S. Angus; S. Verlarde; B. Golitz; X. He; C. Santos; D. Darr; K. Gallagher; L. Graves; C. Perou; L. Carey; H. S. Earp; G. Johnson

doi:10.1158/2159-8290.cd-16-0653

Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex

J. Zawistowski, M. Miller, D. Goulet, T. Stuhlmiller, A. Beltran, J. Olivares-Quintero, D. Singh, N. Sciaky, J. Parker, N. Rashid, X. Chen, J. Duncan, M. Whittle, S. Angus, S. Verlarde, B. Golitz, X. He, C. Santos, D. Darr, K. GallagherL. Graves, C. Perou, L. Carey, H. S. Earp, G. Johnson

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer Discovery
Volume	7
DOIs	https://doi.org/10.1158/2159-8290.cd-16-0653
State	Published - Jan 1 2017

Disciplines

Pharmacy and Pharmaceutical Sciences

Access to Document

10.1158/2159-8290.cd-16-0653License: Unspecified

https://pubmed.ncbi.nlm.nih.gov/28108460/

Cite this

Zawistowski, J., Miller, M., Goulet, D., Stuhlmiller, T., Beltran, A., Olivares-Quintero, J., Singh, D., Sciaky, N., Parker, J., Rashid, N., Chen, X., Duncan, J., Whittle, M., Angus, S., Verlarde, S., Golitz, B., He, X., Santos, C., Darr, D., ... Johnson, G. (2017). Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex. Cancer Discovery, 7. https://doi.org/10.1158/2159-8290.cd-16-0653

Zawistowski, J, Miller, M, Goulet, D, Stuhlmiller, T, Beltran, A, Olivares-Quintero, J, Singh, D, Sciaky, N, Parker, J, Rashid, N, Chen, X, Duncan, J, Whittle, M, Angus, S, Verlarde, S, Golitz, B, He, X, Santos, C, Darr, D, Gallagher, K, Graves, L, Perou, C, Carey, L, Earp, HS & Johnson, G 2017, 'Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex', Cancer Discovery, vol. 7. https://doi.org/10.1158/2159-8290.cd-16-0653

@article{a730ac82688d435ca45831ce7a337207,

title = "Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex",

author = "J. Zawistowski and M. Miller and D. Goulet and T. Stuhlmiller and A. Beltran and J. Olivares-Quintero and D. Singh and N. Sciaky and J. Parker and N. Rashid and X. Chen and J. Duncan and M. Whittle and S. Angus and S. Verlarde and B. Golitz and X. He and C. Santos and D. Darr and K. Gallagher and L. Graves and C. Perou and L. Carey and Earp, {H. S.} and G. Johnson",

year = "2017",

month = jan,

day = "1",

doi = "10.1158/2159-8290.cd-16-0653",

language = "American English",

volume = "7",

journal = "Cancer Discovery",

}

TY - JOUR

T1 - Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex

AU - Zawistowski, J.

AU - Miller, M.

AU - Goulet, D.

AU - Stuhlmiller, T.

AU - Beltran, A.

AU - Olivares-Quintero, J.

AU - Singh, D.

AU - Sciaky, N.

AU - Parker, J.

AU - Rashid, N.

AU - Chen, X.

AU - Duncan, J.

AU - Whittle, M.

AU - Angus, S.

AU - Verlarde, S.

AU - Golitz, B.

AU - He, X.

AU - Santos, C.

AU - Darr, D.

AU - Gallagher, K.

AU - Graves, L.

AU - Perou, C.

AU - Carey, L.

AU - Earp, H. S.

AU - Johnson, G.

PY - 2017/1/1

Y1 - 2017/1/1

UR - https://cufind.campbell.edu/pharmacy/2326

UR - https://pubmed.ncbi.nlm.nih.gov/28108460/

U2 - 10.1158/2159-8290.cd-16-0653

DO - 10.1158/2159-8290.cd-16-0653

M3 - Article

VL - 7

JO - Cancer Discovery

JF - Cancer Discovery

ER -

Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex

Disciplines

Access to Document

Other files and links

Cite this